Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Modified feeding regimen for critically ill adults guided by a feeding-intolerance prediction model

Official title: Modifying Feeding Protocols for Critically Ill Patients (mNEED) Based on a Predictive Model of Feeding Intolerance in Critically Ill Patients: a Multicentre, Cohorts Randomized, Controlled Trial

Run by The First Hospital of Jilin University · NCT06827275 · Data updated 2026-11-12

This trial tests whether using a prediction model to guide enteral feeding schedules helps critically ill adult ICU patients tolerate and receive nutrition better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment2250 (estimated)
SponsorThe First Hospital of Jilin University
Academic / other
Drugs / interventionschemotherapy
Locations2 sites (Changchun, Jilin and 1 other locations)
StatusRecruiting
StartedFebruary 25, 2025
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedSeptember 3, 2026
Trial IDNCT06827275 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) admitted to a participating ICU with organ dysfunction within 24 hours (SOFA ≥2), expected to stay >48 hours, unable to eat orally, and with no contraindication to enteral nutrition are ideal candidates.

Probably not a fit

Patients with severe gastrointestinal failure (AGI level IV), those who recently received enteral nutrition, those receiving palliative care with expected survival <48 hours, pregnant patients, or those on long-term immunosuppression or active chemo/radiotherapy are excluded and unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

mNEED is a multicenter, cluster-randomized, controlled trial comparing a modified enteral feeding regimen guided by a feeding-intolerance prediction model to usual feeding practice in adult ICUs. ICUs (clusters) in Grade 2+ hospitals are randomized to apply the model-based feeding protocol or continue standard care, and eligible patients are adults with recent organ failure (SOFA ≥2), expected ICU stay >48 hours, unable to eat orally and without enteral nutrition contraindications. The intervention adjusts the enteral feeding process based on predicted risk of feeding intolerance, with outcomes focused on feeding tolerance, nutrition delivery, and clinical course during the ICU stay. Key exclusions include recent enteral nutrition within three days, AGI level IV, expected imminent death, pregnancy, long-term immunosuppression, active chemo/radiotherapy, or concurrent trial participation.

Why it matters

Potential benefit: If successful, the approach could reduce feeding intolerance and improve the amount of nutrition delivered to critically ill patients, which may lower complications and support recovery.

How similar studies have gone: Protocolized enteral feeding and some predictive tools have shown modest improvements in nutrition delivery and reduced intolerance in prior studies, but cluster-randomized trials using model-guided regimens are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age 18 or older Failure of one or more organ systems within 24 hours of admission to the ICU (SOFA score ≥2) Expected to stay in ICU for more than 48 hours Inability to eat orally No EN taboo

ICU Selection Criteria:

ICU in Grade 2 or above hospitals ICU with the ability to carry out intensive care and monitor patient FI ICU type: emergency, medical, surgical, neurosurgical, or comprehensive ICU

Exclusion Criteria:

Patients who have received EN treatment in the past three days AGI Level IV patients Receiving palliative care and expected to die within 48 hours Pregnancy Long-term use of steroids or other immunosuppressants Patients undergoing radiotherapy or chemotherapy for malignant diseases Participation in other clinical studies

ICU Exclusion Criteria:

ICU that refuses to participate in the study ICU that has not passed the ethical review Pediatric ICU

Where it's running

  • The First Hospital of Jilin University
    Changchun, Jilin, China
    Recruiting
  • Jilin University, Chaoyang District, Changchun City, Jilin Province
    Changchun, Jilin, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.